A ferroptosis-related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study.

Jiaxin DongTao TaoJiaao YuHuisi ShanZiyu LiuGuangzhao ZhengZhihong LiWanyi SituXiao Zhu Zesong Li

Published in: Cancer reports (Hoboken, N.J.) (2023)

In conclusion, the prognostic model based on FLncSig can alleviate the difficulty in predicting the prognosis and immunotherapy of LUAD patients. The identified FLncSig and the screened drugs exhibit potential for clinical application and provide references for the treatment of LUAD.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
cell death
prognostic factors
peritoneal dialysis
risk assessment
transcription factor
combination therapy
human health